Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Viona Pharmaceuticals Inc

NDC labeler code: 72578

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

105Products (NDC)

Prescription medicines

Show the other 13 medicines

FDA applications for these products

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
September 29, 2026ANDA218361 Mupirocin
MUPIROCIN CALCIUM
Zydus Lifesciences
September 15, 2026ANDA218560 Tretinoin
TRETINOIN
Zydus Lifesciences
March 11, 2026ANDA220267 Cevimeline hydrochloride
CEVIMELINE HYDROCHLORIDE
Zydus Lifesciences
February 26, 2026ANDA216863 Ivermectin
IVERMECTIN
Zydus Lifesciences
February 26, 2026ANDA220103 Dapsone
DAPSONE
Zydus Lifesciences
February 13, 2026ANDA220095 Metronidazole
METRONIDAZOLE
Zydus Lifesciences
February 12, 2026ANDA217815 Ammonium lactate
AMMONIUM LACTATE
Zydus Lifesciences
August 8, 2025ANDA219253 Diltiazem
DILTIAZEM HYDROCHLORIDE
Zydus Lifesciences
August 7, 2025ANDA218056 Prucalopride
PRUCALOPRIDE SUCCINATE
Zydus Lifesciences
March 10, 2025ANDA219661 Methenamine hippurate
METHENAMINE HIPPURATE
Zydus Lifesciences
March 7, 2025ANDA218559 Ketoconazole
KETOCONAZOLE
Zydus Lifesciences
February 20, 2025ANDA218684 Ibuprofen and famotidine
IBUPROFEN AND FAMOTIDINE
Zydus Lifesciences
February 5, 2025ANDA218830 Methimazole
METHIMAZOLE
Square Pharms PLC
December 17, 2024ANDA219120 Lidocaine and prilocaine
LIDOCAINE AND PRILOCAINE
Zydus Lifesciences
October 16, 2024ANDA219251 Fludrocortisone acetate
FLUDROCORTISONE ACETATE
Zydus Lifesciences
July 22, 2024ANDA218991 Valsartan
VALSARTAN
Zydus Lifesciences
May 21, 2024ANDA218063 Theophylline
THEOPHYLLINE
Zydus Lifesciences
May 9, 2024ANDA216284 Dexamethasone
DEXAMETHASONE
Zydus Lifesciences
May 8, 2024ANDA214019 Dapsone
DAPSONE
Zydus Lifesciences
April 25, 2024ANDA218561 Tretinoin
TRETINOIN
Zydus Lifesciences
February 7, 2024ANDA216282 Dexamethasone
DEXAMETHASONE
Zydus Lifesciences
February 7, 2024ANDA216283 Dexamethasone
DEXAMETHASONE
Zydus Lifesciences
December 13, 2023ANDA214085 Darunavir
DARUNAVIR
Zydus Lifesciences
September 19, 2023ANDA216587 Clindamycin
CLINDAMYCIN PHOSPHATE
Zydus Lifesciences
August 16, 2023ANDA202761 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE
Zydus Lifesciences
Show the other 41 applications
ApprovedApplicationMedicineSponsor
May 3, 2023ANDA215705 Sucralfate
SUCRALFATE
Zydus Lifesciences
April 21, 2023ANDA217128 Metronidazole
METRONIDAZOLE
Zydus Lifesciences
April 10, 2023ANDA212294 Tavaborole
TAVABOROLE
Zydus Lifesciences
April 4, 2023ANDA211069 Acetazolamide
ACETAZOLAMIDE
Zydus Lifesciences
March 23, 2023ANDA217471 Loperamide hydrochloride
LOPERAMIDE HYDROCHLORIDE
Zydus Lifesciences
February 28, 2023ANDA206770 Acyclovir
ACYCLOVIR
Zydus Lifesciences
January 9, 2023ANDA205443 Febuxostat
FEBUXOSTAT
Zydus Lifesciences
November 4, 2022ANDA215666 Bisoprolol fumarate and hydrochlorothiazide
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Cadila
August 2, 2022ANDA215210 Ivermectin
IVERMECTIN
Zydus Lifesciences
July 25, 2022ANDA215680 Bisoprolol fumarate
BISOPROLOL FUMARATE
Zydus Lifesciences
June 3, 2022ANDA214553 Adapalene and benzoyl peroxide
ADAPALENE AND BENZOYL PEROXIDE
Zydus Pharms
July 14, 2020ANDA214048 Betamethasone dipropionate
BETAMETHASONE DIPROPIONATE
Zydus Lifesciences
February 10, 2020ANDA208989 Fluocinonide
FLUOCINONIDE
Zydus Lifesciences
November 20, 2019ANDA210198 Desonide
DESONIDE
Cadila
September 24, 2019ANDA205249 Clobetasol propionate
CLOBETASOL PROPIONATE
Zydus Lifesciences
August 19, 2019ANDA210188 Ranolazine
RANOLAZINE
Cadila
March 15, 2019ANDA205974 Acyclovir
ACYCLOVIR
Zydus Lifesciences
February 11, 2019ANDA208358 Triamterene and hydrochlorothiazide
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Cadila
November 8, 2018ANDA207764 Nystatin and triamcinolone acetonide
NYSTATIN AND TRIAMCINOLONE ACETONIDE
Zydus Lifesciences
September 28, 2018ANDA205620 Desoximetasone
DESOXIMETASONE
Zydus Lifesciences
August 28, 2018ANDA090165 Aripiprazole
ARIPIPRAZOLE
Square Pharms
August 28, 2018ANDA204189 Gemfibrozil
GEMFIBROZIL
Cadila
July 16, 2018ANDA208767 Clindamycin
CLINDAMYCIN PHOSPHATE
Zydus Lifesciences
May 31, 2018ANDA207774 Doxycycline
DOXYCYCLINE HYCLATE
Zydus Lifesciences
May 25, 2018ANDA207767 Nystatin
NYSTATIN
Zydus Lifesciences
March 9, 2018ANDA208187 Tizanidine
TIZANIDINE HYDROCHLORIDE
Cadila
October 30, 2017ANDA207773 Doxycycline
DOXYCYCLINE HYCLATE
Zydus Lifesciences
September 19, 2017ANDA205206 Desoximetasone
DESOXIMETASONE
Zydus Lifesciences
September 14, 2017ANDA209966 Modafinil
MODAFINIL
Cadila
August 23, 2017ANDA091390 Candesartan cilexetil
CANDESARTAN CILEXETIL
Zydus Lifesciences
July 10, 2017ANDA090961 Memantine hydrochloride
MEMANTINE HYDROCHLORIDE
Zydus Lifesciences
June 1, 2017ANDA205798 Mirtazapine
MIRTAZAPINE
Square Pharms PLC
May 30, 2017ANDA208970 Felbamate
FELBAMATE
Zydus Lifesciences
November 16, 2016ANDA206560 Metronidazole
METRONIDAZOLE
Cadila
May 24, 2016ANDA206747 Voriconazole
VORICONAZOLE
Cadila
March 25, 2016ANDA204313 Acyclovir
ACYCLOVIR
Cadila
September 7, 2012ANDA077652 Levofloxacin
LEVOFLOXACIN
Zydus Lifesciences
July 6, 2009ANDA079089 Bicalutamide
BICALUTAMIDE
Adaptis
October 16, 2006ANDA077625 Zonisamide
ZONISAMIDE
Zydus Lifesciences
April 21, 2005ANDA077078 Metformin hydrochloride
METFORMIN HYDROCHLORIDE
Zydus Lifesciences
April 20, 2005ANDA077060 Metformin hydrochloride
METFORMIN HYDROCHLORIDE
Zydus Lifesciences

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2025

  1. October 6, 2025 · Class II · Ongoing · D-0016-2026 · Tavaborole

    Discoloration

    Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar, Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-102-04.

  2. August 12, 2025 · Class II · Ongoing · D-0595-2025 · Tavaborole

    Discoloration

    Tavaborole Topical Solution 5%, 10 mL per glass bottle, Rx Only, For Topical Use Only, Manufactured by: Zydus Lifesciences Ltd., Changodar Ahmedabad, India. Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016.

2024

  1. December 10, 2024 · Class II · Ongoing · D-0171-2025 · Dapsone

    Crystallization

    Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack

  2. December 10, 2024 · Class II · Ongoing · D-0172-2025 · Dapsone

    Crystallization

    Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03. packaged in an Airless pump pack

  3. October 29, 2024 · Class II · Ongoing · D-0038-2025 · Dapsone

    Crystallization

    Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.

  4. September 24, 2024 · Class II · Ongoing · D-0011-2025 · Dapsone

    Crystallization

    Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.

2021

  1. December 27, 2021 · Class II · Terminated · D-0392-2022 · Metformin hydrochloride

    CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

    Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE bottles NDC# 72578-036-01

  2. June 1, 2021 · Class II · Terminated · D-0640-2021 · Metformin hydrochloride

    CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

    Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 Tablets, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. Distributed by: Viona Pharmaceuticals Inc. Cranford, NJ 07016 NDC 72578-036-01

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →